Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
Zero Sodium Peritoneal Dialysate Protocol Study

Jeffrey Testani

Watch time: 7m 55s
DGK 2019: REPORT-HF

Christiane Angermann

Watch time: 2m 36s
ESC 2019: Actin-myosin modulation in cardiomyopathy - Prof Christine E Seidman

Christine E Seidman

Watch time: 5m 21s
EASD 2019: EXSCEL - Dr Lindsay E Clegg

Watch time: 6m 1s
ESC 2019: Commentary on the TRANSITION-CHF and PIONEER-HF Studies

Andrew JS Coats, Scott Solomon

Watch time: 5m 58s
AHA 2019: Updates from the DAPA-HF trial — Dr Harriette Van Spall and Dr Mikhail N Kosiborod

Harriette Van Spall, Mikhail Kosiborod

Watch time: 7m 44s
HFA 2020: Eligibility for sacubitril/valsartan in HF across the EF spectrum

Gianluigi Savarese

Watch time: 7m 56s
HFSA 2020: Primary HELP Trial Results - Dr Barry A Borlaug

Barry Borlaug

Watch time: 7m 58s
ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF, Including HFpEF

Deepak L Bhatt, Harriette Van Spall

Watch time: 16m 6s
AHA 21: Results From Rose Clinical Trial CETPi Lowers LDL-C in Patients Taking High Intensity Statins

Stephen Nicholls

Watch time: 5m 41s
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Christiane Angermann

Watch time: 22m 15s
Masterclass on Building A Legacy With Dr. Milton Packer

Milton Packer, Harriette Van Spall

Watch time: 55m 12s
HF 22: CLOROTIC: Combined Loop With Thiazide Diuretics in Pts With Decompensated HF

Watch time: 4m 19s
APSC Journal Club: Landmark Trials of SGLT2 Inhibitors in HFrEF

Jack Tan Wei Chieh, Jonathan Jiunn Liang Yap, Wishnu Aditya, et al

Watch time: 1h 18m 6s
JAPSC Mohamed Supplement 2

Riyadh Qasim

Watch time: 2s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s